Primary Care Diabetes
Volume 2, Issue 3 , Pages 141-146 , September 2008

Screening coverage for diabetic retinopathy using a three-field digital non-mydriatic fundus camera

  • Enrique Soto-Pedre

      Affiliations

    • Corresponding Author InformationCorresponding author at: European Innovative Biomedicine Institute (EIBI), C/Jardines #2, Apt. 1-G, 39700 Castro-Urdiales (Cantabria), Spain. Tel.: +34 609409113.
    • ,
  • Maria C. Hernaez-Ortega

Received 9 October 2007 ,Revised 17 March 2008 ,Accepted 28 April 2008.

References 

  1. In:  Kohner EM,  Porta M editor. Screening for Diabetic Retinopathy in Europe: A Field Guide-book. Geneva: World Health Organization; 1990;
  2. WHO/IDF Europe . Diabetes care and research in Europe: the Saint Vincent Declaration. Diabet. Med. 1990;7:360
  3. Klein BEK, Davis MD, Segal P. Diabetic retinopathy: assessment of severity and progression. Ophthalmology. 1984;91:10–17
  4. Brechner RJ, Cowie CC, Howie LJ, Herman WH, Will JC, Harris MI. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA. 1993;270:1714–1718
  5. American Diabetes Association . Screening for diabetic retinopathy. Diabetes Care. 1997;20(Suppl. 1):28–30
  6. Trento M, Bajardi M, Borgo E, et al. Perceptions of diabetic retinopathy and screening procedures among diabetic people. Diabet. Med. 2002;19:810–813
  7. Wilson A, Baker R, Thompson J, Grimshaw G. Coverage in screening for diabetic retinopathy according to screening provision: results from a national survey in England and Wales. Diabet. Med. 2004;21:271–278
  8. Grupo de Trabajo de la Conferencia Nacional de Diabetes Mellitus, Documentos de los grupos de trabajo de la conferencia nacional de diabetes mellitus, Ministerio de Sanidad y Consumo, Madrid, 1992.
  9. Ministerio de Sanidad y Consumo, Consenso para la atención a las personas con diabetes en España, Ministerio de Sanidad y Consumo, Madrid, 1995.
  10. European Diabetes Policy Group, A Desktop Guide to Type 2 Diabetes Mellitus, International Diabetes Federation (European Region), Brussels (Belgium), 1998.
  11. European Diabetes Policy Group, A Desktop Guide to Type 1 (Insulin Dependent) Diabetes Mellitus, International Diabetes Federation (European Region), Brussels (Belgium), 1998.
  12. Moss SE, Klein R, Klein BEK. Factors associated with having eye examinations in persons with diabetes. Arch. Fam. Med. 1995;4:529–534
  13. Schoenfeld ER, Greene JM, Wu SY, Leske MC. Patterns of adherence to diabetes vision care guidelines. Baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology. 2001;108:563–571
  14. Soto-Pedre E, Hernaez-Ortega MC, Piniés JA. Duration of diabetes and screening coverage for retinopathy among type 2 diabetes. Ophthalmic Epidemiol. 2007;14(2):76–79
  15. World Medical Association, Declaration of Helsinki: Ethical Principals for Research Involving Human Subjects (As Amended in Tokyo), World Medical Association, Ferney-Voltaire, France, 2004.
  16. Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular oedema disease severity scales. Ophthalmology. 2003;110:1677–1682
  17. Snedecor GW, Cochran WG. Statistical Methods. Ames, IO: Iowa State University Press; 1989;
  18. Fleiss JL. Statistical Methods for Rates and Proportions. New York: John Wiley & Sons, Inc.; 1981;
  19. StataCorp, Stata Reference Manual, Release 5.0, Stata Corporation, College Station, TX, 1997.
  20. Lopez I, Diez A, Velilla S, Rueda A, Alvarez A, Pastor JC. Prevalence of diabetic retinopathy and eye care in a rural area of Spain. Ophthalmic Epidemiol. 2002;9(3):205–214
  21. Arteagoitia JM, Larrañaga MI, Rodriguez JL, Fernandez I, Piniés JA. Incidence, prevalence and coronary heart disease risk level in known type 2 diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia. 2003;46:899–909
  22. Teruel C, Fernández-Real JM, Ricart W, Valent R, Vallés M. Prevalence of diabetic retinopathy in the region of Girona. Study of related factors (Spanish). Arch. Soc. Esp. Oftalmol. 2005;80:85–92
  23. McCarty CA, Lloyd-Smith CW, Lee SE, Livingston PM, Stanislavsky YL, Taylor HR. Use of eye care services by people with diabetes: the Melbourne Visual Impairment Project. Br. J. Ophthalmol. 1998;82:410–414
  24. Morgan CL, Currie CJ, Stott NC, Smithers M, Butler CC, Peters JR. The prevalence of multiple diabetes-related complications. Diabet. Med. 2000;17:146–151
  25. Wong TY, Klein R, Islam A, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am. J. Ophthalmol. 2006;141:446–455
  26. McKay R, McCarty CA, Taylor HR. Diabetic retinopathy in Victoria, Australia: the visual impairment project. Br. J. Ophthalmol. 2000;84:865–870
  27. Massin P, Aubert JP, Erginay A, et al. Screening for diabetic retinopathy: the first telemedical approach in a primary care setting in France. Diabetes Metab. 2004;30:451–457
  28. Malone JI, Morrison AD, Pavan PR, Cuthbertson DD. The Diabetes Control and Complications Trial. Prevalence and significance of retinopathy in subjects with type 1 diabetes less than 5 years’ duration screened for the Diabetes Control and Complications Trial. Diabetes Care. 2001;24:522–526
  29. Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287:2563–2569
  30. UK Prospective Diabetes Study (UKPDS) Group. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus. Arch. Ophthalmol. 2004;122:1631–1640
  31. Ryder RE, Kong N, Bates AS, Sim J, Welch J, Kritzinger EE. Instant electronic imaging systems are superior to Polaroid at detecting sight-threatening diabetic retinopathy. Diabet. Med. 1998;15(3):254–258
  32. Li HK. Telemedicine and ophtalmology. Surv. Ophthalmol. 1999;44:61–72
  33. Liesenfeld B, Kohner E, Piehlmeier W, et al. A telemedical approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care. 2000;23(3):345–348
  34. Hernaez-Ortega MC, Soto-Pedre E, Vazquez JA, Gutierrez MA, Asua J. Study of the efficiency of a non-mydriatic retinal camera in the diagnosis of diabetic retinopathy (Spanish). Rev. Clin. Esp. 1998;198:194–199
  35. Scanlon PH, Foy C, Malhotra R, Aldington SJ. The influence of age, duration of diabetes, cataract, and pupil size on image quality in digital photographic retinal screening. Diabetes Care. 2005;28:2448–2453
  36. Von Wendt G, Heikkila K, Summanen P. Assessment of diabetic retinopathy using two-field 60 degrees fundus photography. A comparison between red-free, black-and-white prints and colour transparencies. Acta Ophthalmol. Scand. 1999;77(6):638–647
  37. Von Wendt G, Ronnholm P, Heikkila K, Summanen P. A comparison between one- and two-field 60 degree fundus photography when screening for diabetic retinopathy. Acta Ophthalmol. Scand. 2000;78(1):14–20
  38. Saari JM, Summanen P, Kivelä T, Saari KM. Sensitivity and specificity of digital retinal images in grading diabetic retinopathy. Acta Ophthalmol. Scand. 2004;82:126–130
  39. Murgatroyd H, Ellingford A, Cox A, et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br. J. Ophthalmol. 2004;88:920–924
  40. Greenlick MR, Bailey JW, Wild J, Grover J. Characteristics of men most likely to respond to an invitation to be screened. Am. J. Public Health. 1979;69:1011–1015
  41. Rothman KJ. Modern Epidemiology. Boston: Little, Brown & Company; 1986;

☆ Presented in part at the Annual Meeting of the Spanish Society of Ophthalmology (SEO), 10 October 2003, Valencia, Spain. 2006 ESTEVE Award finalist in medical studies (Campaign “Diabetes may have damaged your eyes”, Cantabria-Spain, 2002), 14 February 2007, Spanish National Research Council (CSIC), Madrid, Spain.

PII: S1751-9918(08)00037-5

doi: 10.1016/j.pcd.2008.04.003

Primary Care Diabetes
Volume 2, Issue 3 , Pages 141-146 , September 2008

Article Tools

* Image Usage & Resolution